CAR T cell therapy has become an increasingly common treatment for patients with diffuse large B-cell lymphoma, (DLBCL), follicular lymphoma (FL), and mantle cell lymphoma. This presentation discusses how it works, who is a good candidates for CAR T-cell therapy, and the risks and benefits of the treatment.

After transplant or CAR T-cell therapy, patients often experience a decline in their cognitive abilities, such as finding the right word, multitasking, or completing complex tasks. This presentation explores potential causes of cognitive decline and discusses interventions that can help manage them.

Patients and their partners may have difficulty with intimacy and sexual activity after transplant or CAR T-cell therapy. This presentation explores strategies for acknowledging and addressing these issues.

When graft-versus-host disease (GVHD) affects the mouth (oral GVHD), it can cause pain, problems with eating, and speech difficulties. This video discusses symptoms of oral GVHD, treatment options, and what patients can do to help manage the problem.